While the reduction of AST and ALT by HK L-137 was within the normal range in this study, these reports suggest that lowering serum ALT within the normal range may reduce the risk of type 2 diabetes, metabolic syndrome, and coronary heart disease. This evidence concerns the gene GPT and metabolic syndrome.